Published on in Vol 11, No 1 (2022): January

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/31925, first published .
Connectivity-Guided Theta Burst Transcranial Magnetic Stimulation Versus Repetitive Transcranial Magnetic Stimulation for Treatment-Resistant Moderate to Severe Depression: Magnetic Resonance Imaging Protocol and SARS-CoV-2–Induced Changes for a Randomized Double-blind Controlled Trial

Connectivity-Guided Theta Burst Transcranial Magnetic Stimulation Versus Repetitive Transcranial Magnetic Stimulation for Treatment-Resistant Moderate to Severe Depression: Magnetic Resonance Imaging Protocol and SARS-CoV-2–Induced Changes for a Randomized Double-blind Controlled Trial

Connectivity-Guided Theta Burst Transcranial Magnetic Stimulation Versus Repetitive Transcranial Magnetic Stimulation for Treatment-Resistant Moderate to Severe Depression: Magnetic Resonance Imaging Protocol and SARS-CoV-2–Induced Changes for a Randomized Double-blind Controlled Trial

Stefan Pszczolkowski   1, 2 * , PhD ;   William J Cottam   1, 2, 3 * , PhD ;   Paul M Briley   4, 5 , PhD ;   Sarina J Iwabuchi   2 , PhD ;   Catherine Kaylor-Hughes   4 , PhD ;   Abdulrhman Shalabi   4, 6 , MBChB, MBMSc ;   Ben Babourina-Brooks   1, 3 , PhD ;   Adam Berrington   3 , PhD ;   Shaun Barber   7 , PhD ;   Ana Suazo Di Paola   7 , MSc ;   Andrew Blamire   8 , PhD ;   R Hamish McAllister-Williams   8, 9 , MD, PhD ;   Jehill Parikh   8 , PhD ;   Mohamed Abdelghani   10 , MBBCh, MSc ;   Lars Matthäus   11 , Dr Rer Nat ;   Ralf Hauffe   11 , Dr-Ing ;   Peter Liddle   4 , BMBCh, PhD ;   Dorothee P Auer   1, 2, 3 , MD, PhD ;   Richard Morriss   1, 4, 12, 13 , MBChB, MMedSci, MD

1 NIHR Nottingham Biomedical Research Centre, University of Nottingham, Nottingham, United Kingdom

2 Mental Health and Clinical Neurosciences, School of Medicine, University of Nottingham, Nottingham, United Kingdom

3 Sir Peter Mansfield Imaging Centre, University of Nottingham, Nottingham, United Kingdom

4 Institute of Mental Health, School of Medicine, University of Nottingham, Nottingham, United Kingdom

5 Nottinghamshire Healthcare NHS Foundation Trust, Nottingham, United Kingdom

6 Faculty of Medicine, University of Jeddah, Jeddah, Saudi Arabia

7 Leicester Clinical Trials Unit, University of Leicester, Leicester, United Kingdom

8 Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, United Kingdom

9 Cumbria, Northumberland, Tyne and Wear NHS Foundation Trust, Newcastle upon Tyne, United Kingdom

10 Camden and Islington NHS Foundation Trust, London, United Kingdom

11 eemagine Medical Imaging Solutions GmbH, Berlin, Germany

12 NIHR MindTech MedTech and in Vitro Centre, Nottingham, United Kingdom

13 NIHR Applied Research Collaboration East Midlands, Nottingham, United Kingdom

*these authors contributed equally

Corresponding Author:

  • Richard Morriss, MBChB, MMedSci, MD
  • Institute of Mental Health
  • School of Medicine
  • University of Nottingham
  • Room C20, Jubilee Campus
  • Wollaton Road
  • Nottingham, NG8 1BB
  • United Kingdom
  • Phone: 44 0115 823 0427
  • Email: richard.morriss@nottingham.ac.uk